Posted the excerpt from an MBRX press release today. Found it interesting seeing as how we are patiently waiting for TNBC tests to begin "The company, Moleculin (MBRX), recently recruited 3 patients in 6 weeks in Poland, whereas in the U.S. it took a full year to build a similar, complete cohort. The company now has 2 clinical trials with patients enrolled in Poland."